Trends in the survival of american indian, hispanic, and non‐hispanic white cancer patients in new mexico and arizona, 1969‐1994

Abstract

Increased cancer control efforts were associated with earlier diagnosis, more patients receiving appropriate therapy, and improved survival for non-Hispanic whites, American Indians, and Hispanics. However, the improvement was greatest for non-Hispanic whites, and disparities in survival results for the different ethnic groups widened over the period of study. Cancer control strategies need to address the specific social, cultural, and biologic prognostic factors that affect different ethnic groups if disparities in outcomes are to be reduced.

Adherence to Physician Recommendation to Colorectal Cancer Screening Colonoscopy Among Hispanics

“…1 This low CRC-screening rate may contribute to Hispanics' later stage of disease at presentation and poorer prognosis than non-Hispanic Whites. [7][8][9][10][11] Many studies have investigated the problem of low overall screening rates among Hispanics. [12][13][14][15][16][17][18] Some have focused on the patient's perspective and explored a wide spectrum of social, cultural and behavioral factors that could play a role in modifying patients' willingness to undergo CRC screening.…”

Breast cancer survival of American Indian/Alaska Native women, 1973–1996

“…American Indian women have poorer breast cancer five-year survival than women of other races, after controlling for stage at diagnosis and initial treatment (Frost et al 1996). In addition, American Indians from New Mexico and Arizona are significantly less likely than nonHispanic Whites to receive appropriate cancer therapy after diagnosis of cancer of the breast, cervix and rectum, or melanoma (Gilliland et al 1998). Using breast cancer data from the Surveillance, Epidemiology, and End Results (SEER) Program of the National Cancer Institute, we examined differences in five-year survival of American Indian/Alaska Native women compared with non-Hispanic White women 40 years and older after diagnosis of first invasive breast cancer, 1973 -1996, in all 11 geographical sites of the SEER Program.…”

Testicular cancer: A narrative review of the role of socioeconomic position from risk to survivorship

“…Many studies have examined race as a proxy for SEP in the United States [12][13][14]. As we were concerned about direct measures of SEP and previous papers have reported on racial differences in TGCT [2,[15][16][17], this study does not include papers that focused only on racial disparities in TGCT risk, diagnosis, treatment, and survival. We concentrate our review on the association of SEP with risk factors for developing TGCT, as well as SEP differences in diagnosis, treatment, survival, and survivorship in TGCT patients.…”